Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2007
08/30/2007WO2007095746A1 Cancerous disease modifying antibodies
08/30/2007WO2007095745A1 Cancerous disease modifying antibody 141205-02
08/30/2007WO2007095739A1 Analysis of thin liquid films
08/30/2007WO2007095729A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
08/30/2007WO2007095678A1 Α SYSTEM FOR DETECTING ONE OR MORE PREDETERMlNED OPTICALLY DERIVABLE CHARACTERISTICS OF A SAMPLE
08/30/2007WO2007081543A9 High-throughput cell-based assays fabricated with integrated silicon and cell culture technologies
08/30/2007WO2007079314A3 METHOD TO DETERMINE WHETHER A COMPOUND IS A CELLULAR GSTπ INHIBITOR
08/30/2007WO2007070310A3 Microreplicated microarrays
08/30/2007WO2007063363A3 Method for determining the concentration of the adipocytic form of the fatty acid binding protein (a-fabp, fabp4, p2)
08/30/2007WO2007059948A3 Detector device for detecting the presence of a gas
08/30/2007WO2007059007A3 Markers of definitive endoderm
08/30/2007WO2007056523A3 Methods for diagnosing and monitoring the progression of cancer
08/30/2007WO2007056411A3 Method of producing pan-specific antibodies
08/30/2007WO2007035082A9 Immortalized fetal liver cell lines
08/30/2007WO2007020522A3 Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
08/30/2007WO2007013360A3 Pancreatic cancer related gene cst6 and gabrp
08/30/2007WO2006127731A3 Inhibitors of pghs-2transactivator activity
08/30/2007WO2006117225A3 Competitive n-hybrid system
08/30/2007WO2006081521A3 Methods for diagnosis and intervention of hepatic disorders
08/30/2007WO2005054480A3 Insect resistant cotton plants and methods of detecting the same
08/30/2007WO2004048540A3 Mracs as modifiers of the rac pathway and methods of use
08/30/2007US20070204352 Regulators of protein misfolding and aggregation and methods of using the same
08/30/2007US20070203588 Process control system
08/30/2007US20070203343 Cyanine Dye Labelling Reagents
08/30/2007US20070203332 Methods and compositions for targeted drug delivery
08/30/2007US20070203327 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substanaces
08/30/2007US20070203089 Compositions and methods for the treatment of ophthalmic disease
08/30/2007US20070203088 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
08/30/2007US20070203083 Methods Of Regulating Metabolism And Mitochondrial Function
08/30/2007US20070203065 Insulin-Independent, Bone Morphogenetic Protein (Bmp)-Mediated Uptake Of Blood Glucose By Peripheral Cells And Tissues
08/30/2007US20070203061 Adiponectin expression-inducing agents and uses thereof
08/30/2007US20070203059 Targeted Drug-Formaldehyde Conjugates And Methods Of Making And Using The Same
08/30/2007US20070202611 Simple membrane assay method and kit
08/30/2007US20070202609 Apparatus and methods for increasing lateral mass transfer over molecule sensors
08/30/2007US20070202606 Devices And Methods For Measuring Clinically Relevant Analytes In Fluids
08/30/2007US20070202605 Methods For Identifying And Measuring S-Nitrosothiol Bonds In Heme-Containing Cells And Molecules
08/30/2007US20070202604 cleaving glucosamine-glucuronic acid linkages in linear polysaccharides, comprising reacting heparin or heparan sulfate with purified heparinases
08/30/2007US20070202602 Method for screening crystallization conditions in solution crystal growth
08/30/2007US20070202576 Labeled-imidazole-Polyethylene glycol compounds; nonpurine- and nonpyrimidine-based nucleotides; nucleotide sequence detectors; polymerization in the presence of deoxynucleotidyl transferase
08/30/2007US20070202567 Diagnostics And Therapeutics For Diseases Associated With Arginyl Aminopeptidase Rnpep (Rnpep)
08/30/2007US20070202566 Hydrolases, Nucleic Acids Encoding Them And Methods For Making And Using Them
08/30/2007US20070202558 ELISA for VEGF
08/30/2007US20070202557 Enzyme immunoassay chip and method
08/30/2007US20070202556 Methods and kits for detection of thromboxane a2 metabolites
08/30/2007US20070202555 Method for judging feature of malignant tumor
08/30/2007US20070202554 Method for determining degree of negative effect of macrophages on vertebrate
08/30/2007US20070202553 Dominant B Cell Epitopes and Methods of Making and Using Thereof
08/30/2007US20070202552 Binding Polypeptides and Uses Thereof
08/30/2007US20070202551 TGFBeta
08/30/2007US20070202550 Novel G protein-coupled receptor protein, its DNA and ligand thereof
08/30/2007US20070202549 Assessing risk of cerebrovascular thrombosis by measuring C4d on platelets
08/30/2007US20070202548 Screening assay to identify inhibitors of the murd enzyme using an activator-independent murd enzyme
08/30/2007US20070202547 Methods For Detecting Substances Which Bind To The Amyloid Precursor Protein Or Beta Amyloid Fragments, And Binding Compounds
08/30/2007US20070202546 Immunoassay Carrier
08/30/2007US20070202545 Determining ghrelin levels in tissue or biofluid; immunoassay, ELISA
08/30/2007US20070202544 Methods For Diagnosing And Treating Endoplasmic Reticulum (er) Stress Diseases
08/30/2007US20070202543 within wells of microplates
08/30/2007US20070202542 Disposable immunodiagnostic test system
08/30/2007US20070202541 Determining whether a substance can modulate the interaction of STAT6 (signal transducer and activator of transcription 6) with NCoA-1,(nuclear coactivator); drug screening; Hodgkin Lymphomas, asthma
08/30/2007US20070202540 Tape stripping methods for analysis of skin disease and pathological skin state
08/30/2007US20070202539 Methods for quantitative proteome analysis of glycoproteins
08/30/2007US20070202538 Multiwell plates having reagents pre-loaded in the wells for use in medical diagnostics, food and beverage testing, environmental monitoring, manufacturing quality control and drug discovery
08/30/2007US20070202537 Biomarkers for als
08/30/2007US20070202536 Methods and compositions for separating rare cells from fluid samples
08/30/2007US20070202535 Methods For Analyzing Interactions Between Proteins And Sugar Chains
08/30/2007US20070202534 CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia
08/30/2007US20070202533 High speed DNA sequencer and method
08/30/2007US20070202530 Devices And Methods For Isolating And Recovering Target Cells
08/30/2007US20070202528 Methods for modulating proteins not previously known as proteases
08/30/2007US20070202527 using animal derived component free (ADCF) cell culture technology; attaching ADCF-adapted cells to microcarrier including an attachment mechanism for attaching filipodia of the cells, growing the cells in ADCF maintenance media, infecting with vaccine media, producing virus within cells, and harvesting
08/30/2007US20070202513 Using shed cellular material as evaluative indicator of cell proliferative disorders
08/30/2007US20070202510 Methods for diagnosing and treating kidney cancer
08/30/2007US20070202501 Proteins Expressed In Ink Cells
08/30/2007US20070202498 comprising at least two chemically different fluorophores, providing a donor and an acceptor respectively, connected together by at least one linker moiety and bonded to a binder moiety; obtaining fluorescence enhancement by energy transfer enabled with binder molecules in diagnostic applications
08/30/2007US20070202497 One Step Oligochromatographic Device And Method Of Use
08/30/2007US20070202496 Liver cancer biomarkers
08/30/2007US20070202495 Use of resistive-pulse sensing with submicrometer pores or nanopores for the detection of the assembly of submicrometer or nanometer sized objects
08/30/2007US20070202493 Device and method for maintaining a plurality of beads in suspension
08/30/2007US20070202491 comparing the marker analytes from the affected areas with the marker analytes from the control area; for consumer products such as those which are topically applied, inhaled, swallowed, ingested, inserted rectally, etc
08/30/2007US20070202490 Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue
08/30/2007US20070202489 comparing the marker analytes from the affected areas with the marker analytes from the control area; for consumer products such as those which are topically applied, inhaled, swallowed, ingested, inserted rectally, etc
08/30/2007US20070202488 harvesting skin tissue from an animal, then identifying marker analyte selected from melanocyte stimulating hormone, microtubules composed of tubulin and associated proteins, and tyrosinases, and evaluating the effect of said test product on the tissue
08/30/2007US20070202486 Method Of Assaying Substance Capable Of Changing Mitochondrial Membrane Potential
08/30/2007US20070202223 Egg Quality Measurement
08/30/2007US20070202137 Device For Sensing Of Motile Living Organisms And Uses Thereof
08/30/2007US20070202132 Allergenic proteins and peptides from dog dander and uses therefor
08/30/2007US20070202123 Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids
08/30/2007US20070202119 Method Of Therapy
08/30/2007US20070202115 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
08/30/2007US20070202114 Higher gene expression in sample indicates tumor is tamoxifen-resistant; drug screening
08/30/2007US20070202112 Detecting vimentin expression and secretion and for characterizing cancer ( prostate cancer);
08/30/2007US20070202110 Angiogenesis Inhibiting Molecules And Their Use In The Treatment And Diagnosis Of Cancer
08/30/2007US20070202109 Method Of Diagnosing Breast Cancer
08/30/2007US20070202107 Novel kinases
08/30/2007US20070202106 Compositions and methods for the treatment of cancer
08/30/2007US20070202105 Recombinant immunoglobulin specific to tumor necrosis factor for treatment and prevention of sepsis, infection and autoimmune diseases
08/30/2007US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders
08/30/2007US20070202097 Monoclonal Antibodies That Recognise Mucosal Addressin Cell Adhesion Molecule-1 (Madcam-1), Soluble Madcam-1 And Uses Thereof
08/30/2007US20070202086 Vascular stem cells and uses thereof
08/30/2007US20070202085 Systems and methods for monitoring immune responses and predicting outcomes in transplant recipients
1 ... 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 ... 3937